Hitachi Ventures, the venture capital arm of Hitachi Group, is based in Munich and focuses on early-stage investments. They support startups tackling technological, social, and environmental challenges in sectors like biotech, data and analytics, manufacturing, and energy. With a first fund of USD 150 million, they invest in seed and Series A rounds. Hitachi Ventures helps portfolio companies leverage Hitachi's global market presence and network for growth. Notable investments include Cure51 and WASE.
